Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study
Version 3 2021-04-23, 12:57Version 3 2021-04-23, 12:57
Version 2 2020-10-23, 13:38Version 2 2020-10-23, 13:38
Version 1 2020-07-14, 11:56Version 1 2020-07-14, 11:56
figure
posted on 2021-04-23, 12:57authored byAsim V. Farooq, Simona Degli Esposti, Rakesh Popat, Praneetha Thulasi, Sagar Lonial, Ajay K. Nooka, Andrzej Jakubowiak, Douglas Sborov, Brian E. Zaugg, Ashraf Z. Badros, Bennie H. Jeng, Natalie S. Callander, Joanna Opalinska, January Baron, Trisha Piontek, Julie Byrne, Ira Gupta, Kathryn Colby
The above summary slide, infographic and plain language summary represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).